About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

AVAILABLENCT03775187

Expanded Access to Burosumab

Individual patient expanded access requests may be considered for patients who have no other treatment options

Lead sponsor: Kyowa Kirin Co., Ltd.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Development Division Project Management Department

CONTACT

609-919-1100 kkd.clintrial.82@kyowakirin.com

Sponsors

Lead Sponsor

Kyowa Kirin Co., Ltd.

Expanded access may be available outside of the US in countries prior to approval by the local regulatory agencies. For full details, please visit the links provided below.

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\-

Exclusion Criteria

•\-

Related studies

Active Not Recruiting

Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners

NCT03745521 · X-Linked Hypophosphatemia

COMPLETEDPhase 1/2

Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age

NCT04188964 · X-linked Hypophosphatemia (XLH)

COMPLETEDPhase 4

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH

NCT04842032 · X-linked Hypophosphatemia (XLH)

COMPLETEDPhase 3

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

NCT02537431 · X-linked Hypophosphatemia

COMPLETEDPhase 1/2

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

NCT01571596 · X-linked Hypophosphatemia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 5, 2025Terms

Trial snapshot

StatusAVAILABLE

Phase—

Enrollment—

Start date—

Last updatedMar 5, 2025

Condition

X-linked Hypophosphatemia Tumor-Induced Osteomalacia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions